SGL5213
Modify Date: 2025-08-29 12:37:14
SGL5213 structure
|
Common Name | SGL5213 | ||
|---|---|---|---|---|
| CAS Number | 1240305-17-2 | Molecular Weight | 669.85 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C37H55N3O8 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of SGL5213SGL5213 is a potent, oral active and low-absorbable sodium-dependent glucose cotransporter 1 (SGLT1) inhibitor, with IC50 values of 29 nM and 20 nM for hSGLT1 and hSGLT2, respectively. SGL5213 has potential to treat type 2 diabetes treatment[1]. |
| Name | SGL5213 |
|---|
| Description | SGL5213 is a potent, oral active and low-absorbable sodium-dependent glucose cotransporter 1 (SGLT1) inhibitor, with IC50 values of 29 nM and 20 nM for hSGLT1 and hSGLT2, respectively. SGL5213 has potential to treat type 2 diabetes treatment[1]. |
|---|---|
| Related Catalog | |
| Target |
IC50: 29nM/20 nM (hSGLT1/ hSGLT2)[1]. |
| References |
| Molecular Formula | C37H55N3O8 |
|---|---|
| Molecular Weight | 669.85 |
| InChIKey | MUBBPBZRFJGZEU-XSPPBVGUSA-N |
| SMILES | COc1cc(C(C)C)c(Cc2ccc(C=CC(C)(C)C(=O)NC(C)(C)C(=O)NCCN(C)C)cc2)cc1C1OC(CO)C(O)C(O)C1O |